ATF-2 Is a Common Nuclear Target of Smad and TAK1 Pathways in Transforming Growth Factor-β Signaling
Open Access
- 1 March 1999
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 274 (13) , 8949-8957
- https://doi.org/10.1074/jbc.274.13.8949
Abstract
No abstract availableKeywords
This publication has 63 references indexed in Scilit:
- SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin‐1Published by Wiley ,2000
- Human Smad3 and Smad4 Are Sequence-Specific Transcription ActivatorsPublished by Elsevier ,1998
- TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4The EMBO Journal, 1997
- Novel Homologues of CSBP/p38 MAP Kinase: Activation, Substrate Specificity and Sensitivity to Inhibition by Pyridinyl ImidazolesBiochemical and Biophysical Research Communications, 1997
- Partnership between DPC4 and SMAD proteins in TGF-β signalling pathwaysNature, 1996
- Receptor-associated Mad homologues synergize as effectors of the TGF-β responseNature, 1996
- A MAP Kinase Targeted by Endotoxin and Hyperosmolarity in Mammalian CellsScience, 1994
- Mechanism of activation of the TGF-β receptorNature, 1994
- Promoter targeting by adenovirus E1a through interaction with different cellular DNA-binding domainsNature, 1994
- Functional antagonism between oncoprotein c-Jun and the glucocorticoid receptorCell, 1990